Literature DB >> 6265600

Evaluation of the drug-induced morphological differentiation of rat glioma cells (C-6) from the aspects of S-100 protein level and con A binding pattern.

K Tabuchi, T Furuta, H Norikane, M Tsuboi, Y Moriya, A Nishimoto.   

Abstract

The intracellular content of the nervous system specific protein S-100 began to increase with 4 days latency following the morphological differentiation of cultured rat glioma cells (C-6) with 1 mM dibutyryl cyclic AMP (dbcAMP), rising to approximately 10-fold over the control level at 15 days after the treatment. The concanavalin A (Con A) binding pattern on the external cell surface of C-6 cells exposed to dbcAMP appeared as a smooth layer of 40-60 nm thickness whereas that of control cells was irregularly thick and patchy. The correlation between morphological and biochemical changes of C-6 cells after dbcAMP treatment is discussed in relation to the mechanism controlling the differentiation of glioma cells.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6265600     DOI: 10.1016/0022-510x(81)90065-4

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  5 in total

1.  Induction of glutathione S-transferase, placental type in T9 glioma cells by dibutyryladenosine 3',5'-cyclic monophosphate and modification of its expression by naturally occurring isothiocyanates.

Authors:  A Hara; N Sakai; H Yamada; T Tanaka; K Kato; H Mori; K Sato
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

2.  S-100 protein in human glial tumours. Qualitative and quantitative studies.

Authors:  K Tabuchi; Y Moriya; T Furuta; R Ohnishi; A Nishimoto
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

3.  Change of morphology and cytoskeletal protein gene expression during dibutyryl cAMP-induced differentiation in C6 glioma cells.

Authors:  Weiwei Hu; Takeshi Onuma; Naoko Birukawa; Masashi Abe; Etsuro Ito; Zhong Chen; Akihisa Urano
Journal:  Cell Mol Neurobiol       Date:  2007-11-14       Impact factor: 5.046

4.  ProBDNF and its receptors are upregulated in glioma and inhibit the growth of glioma cells in vitro.

Authors:  Jing Xiong; Li Zhou; Miao Yang; Yoon Lim; Yu-hong Zhu; Deng-li Fu; Zhi-wei Li; Jin-hua Zhong; Zhi-cheng Xiao; Xin-Fu Zhou
Journal:  Neuro Oncol       Date:  2013-04-10       Impact factor: 12.300

5.  Analysis of the calcium-modulated proteins, S100 and calmodulin, and their target proteins during C6 glioma cell differentiation.

Authors:  D B Zimmer; L J Van Eldik
Journal:  J Cell Biol       Date:  1989-01       Impact factor: 10.539

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.